136 related articles for article (PubMed ID: 36809814)
1. In-situ investigation of solid phase evolution during lyophilization of mannitol-based antibody formulations using an XRPD climate chamber.
Seiler VK; Weber S; Börner M; Witting M; Ehlers S; Nagel N
Eur J Pharm Sci; 2023 May; 184():106407. PubMed ID: 36809814
[TBL] [Abstract][Full Text] [Related]
2. Mannitol as an Excipient for Lyophilized Injectable Formulations.
Thakral S; Sonje J; Munjal B; Bhatnagar B; Suryanarayanan R
J Pharm Sci; 2023 Jan; 112(1):19-35. PubMed ID: 36030846
[TBL] [Abstract][Full Text] [Related]
3. Crystallizing amino acids as bulking agents in freeze-drying.
Horn J; Tolardo E; Fissore D; Friess W
Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
[TBL] [Abstract][Full Text] [Related]
4. The formation and effect of mannitol hemihydrate on the stability of monoclonal antibody in the lyophilized state.
Anko M; Bjelošević M; Planinšek O; Trstenjak U; Logar M; Ahlin Grabnar P; Brus B
Int J Pharm; 2019 Jun; 564():106-116. PubMed ID: 30999044
[TBL] [Abstract][Full Text] [Related]
5. Influence of process conditions on the crystallization and transition of metastable mannitol forms in protein formulations during lyophilization.
Cao W; Xie Y; Krishnan S; Lin H; Ricci M
Pharm Res; 2013 Jan; 30(1):131-9. PubMed ID: 22907420
[TBL] [Abstract][Full Text] [Related]
6. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
7. Mannitol-sucrose mixtures--versatile formulations for protein lyophilization.
Johnson RE; Kirchhoff CF; Gaud HT
J Pharm Sci; 2002 Apr; 91(4):914-22. PubMed ID: 11948529
[TBL] [Abstract][Full Text] [Related]
8. Influence of crystallizing and non-crystallizing cosolutes on trehalose crystallization during freeze-drying.
Sundaramurthi P; Suryanarayanan R
Pharm Res; 2010 Nov; 27(11):2384-93. PubMed ID: 20824310
[TBL] [Abstract][Full Text] [Related]
9. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulations.
Hawe A; Friess W
Eur J Pharm Biopharm; 2006 Nov; 64(3):316-25. PubMed ID: 16875806
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclophosphamide on the solid form of mannitol during lyophilization.
Patel K; Munjal B; Bansal AK
Eur J Pharm Sci; 2017 Apr; 101():251-257. PubMed ID: 28214546
[TBL] [Abstract][Full Text] [Related]
11. Moisture sorption behavior of selected bulking agents used in lyophilized products.
Fakes MG; Dali MV; Haby TA; Morris KR; Varia SA; Serajuddin AT
PDA J Pharm Sci Technol; 2000; 54(2):144-9. PubMed ID: 10822985
[TBL] [Abstract][Full Text] [Related]
12. Crystallization of Cyclophosphamide Monohydrate During Lyophilization.
Munjal B; Zode SS; Bansal AK
J Pharm Sci; 2019 Mar; 108(3):1195-1202. PubMed ID: 30352215
[TBL] [Abstract][Full Text] [Related]
13. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270
[TBL] [Abstract][Full Text] [Related]
14. Influence of processing conditions on the physical state of mannitol--implications in freeze-drying.
Liao X; Krishnamurthy R; Suryanarayanan R
Pharm Res; 2007 Feb; 24(2):370-6. PubMed ID: 17177113
[TBL] [Abstract][Full Text] [Related]
15. Formation of mannitol hemihydrate in freeze-dried protein formulations--a design of experiment approach.
Larsen HM; Trnka H; Grohganz H
Int J Pharm; 2014 Jan; 460(1-2):45-52. PubMed ID: 24239581
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms by which crystalline mannitol improves the reconstitution time of high concentration lyophilized protein formulations.
Kulkarni SS; Suryanarayanan R; Rinella JV; Bogner RH
Eur J Pharm Biopharm; 2018 Oct; 131():70-81. PubMed ID: 30056143
[TBL] [Abstract][Full Text] [Related]
17. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying.
Martini A; Kume S; Crivellente M; Artico R
PDA J Pharm Sci Technol; 1997; 51(2):62-7. PubMed ID: 9146035
[TBL] [Abstract][Full Text] [Related]
18. Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations.
Hawe A; Friess W
Eur J Pharm Sci; 2006 Jun; 28(3):224-32. PubMed ID: 16580820
[TBL] [Abstract][Full Text] [Related]
19. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection.
Liu D; Galvanin F; Yu Y
AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization of the freezing behavior of mannitol-human serum albumin formulations.
Hawe A; Friess W
AAPS PharmSciTech; 2006; 7(4):94. PubMed ID: 17285745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
